BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11173539)

  • 21. A novel SMAD4 gene mutation in seminoma germ cell tumors.
    Bouras M; Tabone E; Bertholon J; Sommer P; Bouvier R; Droz JP; Benahmed M
    Cancer Res; 2000 Feb; 60(4):922-8. PubMed ID: 10706106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
    Hara A; Sakata K; Yamada Y; Kuno T; Kitaori N; Oyama T; Hirose Y; Murakami A; Tanaka T; Mori H
    Oncol Rep; 2005 Aug; 14(2):345-51. PubMed ID: 16012713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-beta signaling in colon cancer cells.
    Li F; Cao Y; Townsend CM; Ko TC
    World J Surg; 2005 Mar; 29(3):306-11. PubMed ID: 15711891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
    Qiu W; Schönleben F; Li X; Su GH
    Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and localization of the transforming growth factor-beta type I receptor and Smads in preneoplastic lesions during chemical hepatocarcinogenesis in rats.
    Park DY; Lee CH; Sol MY; Suh KS; Yoon SY; Kim JW
    J Korean Med Sci; 2003 Aug; 18(4):510-9. PubMed ID: 12923327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
    Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
    Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fhit gene alterations in hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet in rats.
    Tsujiuchi T; Sasaki Y; Oka Y; Konishi Y; Tsutsumi M
    Mol Carcinog; 2003 Mar; 36(3):147-52. PubMed ID: 12619037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue.
    Enomoto A; Esumi M; Yamashita K; Takagi K; Takano S; Iwai S
    J Pathol; 2001 Oct; 195(3):349-54. PubMed ID: 11673833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG site hypermethylation of E-cadherin and Connexin26 genes in hepatocellular carcinomas induced by a choline-deficient L-Amino Acid-defined diet in rats.
    Tsujiuchi T; Shimizu K; Itsuzaki Y; Onishi M; Sugata E; Fujii H; Honoki K
    Mol Carcinog; 2007 Apr; 46(4):269-74. PubMed ID: 17295234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats.
    Tsujiuchi T; Tsutsumi M; Sasaki Y; Takahama M; Konishi Y
    Jpn J Cancer Res; 1999 Sep; 90(9):909-13. PubMed ID: 10551317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
    Gougelet A; Sartor C; Senni N; Calderaro J; Fartoux L; Lequoy M; Wendum D; Talbot JN; Prignon A; Chalaye J; Imbeaud S; Zucman-Rossi J; Tordjmann T; Godard C; Bossard P; Rosmorduc O; Amaddeo G; Colnot S
    Gastroenterology; 2019 Sep; 157(3):807-822. PubMed ID: 31194980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
    Chen J; Zaidi S; Rao S; Chen JS; Phan L; Farci P; Su X; Shetty K; White J; Zamboni F; Wu X; Rashid A; Pattabiraman N; Mazumder R; Horvath A; Wu RC; Li S; Xiao C; Deng CX; Wheeler DA; Mishra B; Akbani R; Mishra L
    Gastroenterology; 2018 Jan; 154(1):195-210. PubMed ID: 28918914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No mutations of the Smad2 gene in human sporadic gastric carcinomas.
    Shitara Y; Yokozaki H; Yasui W; Takenoshita S; Kuwano H; Nagamachi Y; Tahara E
    Jpn J Clin Oncol; 1999 Jan; 29(1):3-7. PubMed ID: 10073143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the Fhit gene in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats.
    Tsujiuchi T; Sasaki Y; Kubozoe T; Tsutsumi M; Konishi Y; Nakae D
    Mol Carcinog; 2002 May; 34(1):19-24. PubMed ID: 12112319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
    Park BJ; Park JI; Byun DS; Park JH; Chi SG
    Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.